The aim of this study is to evaluate the outcome of obstructive colon cancer surgery in terms of days-to-starting adjuvant therapy and quality of life.
Study Type
OBSERVATIONAL
Enrollment
500
Colon resection
Any type of colostomy or ileostomy with or without bowel resection
Any palliative surgery without bowel resection
Medipol University Bahcelievler Hospital
Istanbul, Turkey (Türkiye)
RECRUITINGMedipol Mega Hospital
Istanbul, Turkey (Türkiye)
RECRUITINGTime-to-starting chemotherapy
Surgical procedures will be compared in terms of days-to-first chemotherapy
Time frame: 1 year
Mortality
90-day mortality
Time frame: 3 months
Morbidity
90-day morbidity
Time frame: 3 months
Colorectal cancer-specific quality of life (EORTC QLQ - CR29) at 1 year
The European Organization for Research and Treatment of Cancer, Quality of Life Questionnaire-Colorectal Cancer (EORTC QLQ-CR29) scale will be recorded preoperatively and at 12 months. Surgical procedures will be compared in terms of improvement in EORTC QLQ-CR29 scores.
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.